Humacyte, Inc. logo

Humacyte, Inc. (HUMA)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
0. 43
-0.01
-2.3891%
After Hours
$
0. 45
+0.02 +4.6387%
68.09M Market Cap
- P/E Ratio
- Div Yield
5.94M Volume
-0.9 Eps
$ 0.44
Previous Close
Add Transaction
Day Range
0.42 0.46
Year Range
0.34 1.9
Want to track HUMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.36, signifying a -7.88% move from its prior day's close.

Zacks | 2 days ago
Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade

Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.48, signifying a -4.26% move from its prior day's close.

Zacks | 1 week ago
Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note

Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.5, signifying a -2.86% move from its prior day's close.

Zacks | 2 weeks ago
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) reached $0.59 at the closing of the latest trading day, reflecting a +2.23% change compared to its last close.

Zacks | 3 weeks ago
Is Humacyte, Inc. (HUMA) a Buy as Wall Street Analysts Look Optimistic?

Is Humacyte, Inc. (HUMA) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 4 weeks ago
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.24 per share a year ago.

Zacks | 2 months ago
Humacyte Q2 Earnings Call Highlights

Humacyte Q2 Earnings Call Highlights

Humacyte NASDAQ: HUMA reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license application for dialysis access and begin a first-in-human coronary bypass study.

Marketbeat | 2 months ago
Humacyte, Inc. (HUMA) Rises As Market Takes a Dip: Key Facts

Humacyte, Inc. (HUMA) Rises As Market Takes a Dip: Key Facts

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.73, signifying a +2.33% move from its prior day's close.

Zacks | 2 months ago
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts

Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.63, signifying a -6.44% move from its prior day's close.

Zacks | 2 months ago
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.67, marking a +2.22% move from the previous day.

Zacks | 2 months ago
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights

Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights

Humacyte, Inc. (HUMA) closed at $0.66 in the latest trading session, marking a -1.28% move from the prior day.

Zacks | 2 months ago
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) closed the most recent trading day at $0.71, moving +2.31% from the previous trading session.

Zacks | 3 months ago
Loading...
Load More